Association of renal function, estimated by four equations, with coronary artery disease

Yusuf C Doganer1, James E Rohrer, Umit Aydogan

  • 1Department of Family Medicine, Mayo Clinic, 200 First St. Southwest, Rochester, MN, 55905, USA, ycetindoganer@hotmail.com.

Insights

Impaired renal function is linked to coronary artery disease (CAD) presence and severity. Four estimated glomerular filtration rate (eGFR) equations confirmed this association, with CKD-Epi, MDRD, and C-G being independent predictors of significant CAD.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Statistics

Background:

  • Chronic kidney disease (CKD) and coronary artery disease (CAD) share a bidirectional relationship.
  • Impaired renal function, indicated by estimated glomerular filtration rate (eGFR), is a known risk factor for CAD.
  • Understanding the association between varying degrees of renal dysfunction and CAD extent is crucial for patient management.

Purpose of the Study:

  • To investigate the association between impaired renal function and the presence and severity of CAD.
  • To compare the performance of four different eGFR equations (MDRD, Cockcroft-Gault, CKD-Epi, Mayo Quadratic) in predicting CAD presence and severity.

Main Methods:

  • GFR was estimated in 356 CAD patients using four distinct equations: MDRD, C-G, CKD-Epi, and Mayo Quadratic.
  • CAD severity was categorized based on the number of affected coronary arteries (healthy, single-vessel, multi-vessel disease).
  • Statistical analyses were performed to determine the association between eGFR values and CAD classification, controlling for covariates.

Main Results:

  • Prevalence of eGFR <60 mL/min/1.73 m(2) ranged from 41.5% to 50% across the four equations in patients with significant CAD.
  • eGFR values were significantly lower in patients with single-vessel disease compared to healthy subjects (p < 0.05 for all equations).
  • CKD-Epi, MDRD, and C-G equations independently predicted significant CAD after adjusting for confounding factors (p < 0.05).

Conclusions:

  • Commonly used eGFR equations accurately determine the association between impaired renal function and CAD presence.
  • The CKD-Epi, MDRD, and C-G equations demonstrate significant independent predictive value for CAD severity.
  • These findings highlight the importance of assessing renal function in patients with CAD.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
323
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
564
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
123
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
359
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
338
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
626